For a long time, T1D was associated with a lean phenotype [1] but in the last decades, obesity has been present among these patients even at diagnosis [2]; however, it can also appear after the initiation of insulin treatment that can contribute to weight gain and clinical characteristics of insulin resistance [3]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.